Biocure Technology Inc (TSE:CURE.X)
CNQX:CURE.X
Holding TSE:CURE.X?
Track your performance easily

Biocure Technology Inc (CURE.X) Income Statement

4 Followers

Biocure Technology Inc Income Statement

Last quarter (Q4 2023), Biocure Technology Inc's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, Biocure Technology Inc's net income was C$-23.75K. See Biocure Technology Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 1.06MC$ 1.08MC$ 696.24KC$ 3.90MC$ 2.97MC$ 4.60M
Operating Income
C$ -1.06MC$ -1.08MC$ -696.24KC$ -3.90MC$ -2.97MC$ -4.60M
Net Non Operating Interest Income Expense
---C$ 410.84KC$ 236.35KC$ 135.77K
Other Income Expense
C$ -367.25KC$ -322.70KC$ -292.85KC$ 3.16MC$ 123.92KC$ -59.33K
Pretax Income
C$ -1.44MC$ -1.49MC$ -403.40KC$ -1.15MC$ -3.08MC$ -4.79M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
C$ -178.50KC$ -178.50K----
Net Income Common Stockholders
C$ -1.52MC$ -1.81MC$ -1.45MC$ -1.13MC$ -2.95MC$ -4.74M
Basic EPS
-C$ -0.02----
Diluted EPS
-C$ -0.02----
Basic Average Shares
C$ 92.86MC$ 92.86M----
Diluted Average Shares
C$ 92.86MC$ 92.86M----
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 1.06MC$ 1.08MC$ 696.24KC$ -3.90MC$ -2.97MC$ -4.60M
Net Income From Continuing And Discontinued Operation
C$ -1.52MC$ -1.81MC$ -1.45MC$ -1.13MC$ -2.95MC$ -4.74M
Normalized Income
C$ -755.29KC$ -792.23KC$ -589.35KC$ -535.13KC$ -2.38MC$ -3.52M
Interest Expense
------
EBIT
C$ -1.44MC$ -1.49MC$ -403.40KC$ -1.80MC$ -2.84MC$ -4.65M
EBITDA
C$ -1.44MC$ -1.49MC$ -403.40KC$ -1.80MC$ -2.78MC$ -4.61M
Currency in CAD

Biocure Technology Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis